Bio Protocol vs Solana — how do they compare? Bio Protocol trades at Rp514.67 (market cap Rp1,15T, Rp260,42M 24h volume), while Solana trades at Rp1,371,115 (market cap Rp800,31T, Rp31,71T 24h volume). The key difference: Solana is far larger — about 695.9× Bio Protocol's market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while Solana's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Solana for 66 Days on average.
| BIO | SOL | |
|---|---|---|
Market Cap | Rp1,15T | Rp800,31T |
Volume (24h) | Rp260,42M | Rp31,71T |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 582,3M SOL |
Typical Hold Time | 16 Days | 66 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
Solana is currently trading at Rp1,373,908 with a bearish technical signal, though oscillators show neutral momentum. The asset sits between key support at Rp1,370,545 and resistance at Rp1,405,235. Recent ecosystem developments include SOL Strategies surpassing 31,000 unique wallets and launching a liquid staking platform with over 500,000 SOL staked, indicating growing institutional and retail adoption of Solana infrastructure.
Overall outlook remains cautious with bearish technicals but positive fundamental growth. Key opportunities include Solana's speed advantage for developers and potential altcoin season rotation. Major risks include high volatility, regulatory uncertainty, and technical vulnerabilities that could impact token holders in this developing market phase.
What Pluang investors did over the last 30 days
Latest headlines on both assets
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →SOL is the native token of Solana, an open source project which implements a new, high-performance, permission less blockchain. It is also the fastest blockchain in the world and the fastest growing ecosystem in crypto, with over 400 projects spanning DeFi, NFTs, Web3 and more. The architecture of their blockchain are build based on Proof of History (PoH); a proof for verifying order and passage of time between events.
Read more on SOL →